Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions

Table of Contents

April 2021; Volume 59,Issue 4

Photo Quiz

  • Photo Quiz: A 6-Year-Old Immigrant with Abdominal Pain
    Photo Quiz
    Photo Quiz: A 6-Year-Old Immigrant with Abdominal Pain
    Rikesh Panchmatia, Diana Whellams, Nick Valent, Laura Sauvé
  • Answer to April 2021 Photo Quiz
    Photo Quiz
    Answer to April 2021 Photo Quiz
    Rikesh Panchmatia, Diana Whellams, Nick Valent, Laura Sauvé

Editorial

  • Free
    Is the Patient Infected with SARS-CoV-2?
    Editorial
    Is the Patient Infected with SARS-CoV-2?

    The U.S. Food and Drug Administration currently uses the nasopharyngeal swab specimen as the reference standard for evaluation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) assays. We propose that the patient-infected status algorithm is a superior way to classify whether an individual is infected or not infected.

    Jeffrey D. Klausner, Noah Kojima, Susan M. Butler-Wu

The Brief Case

  • Free
    The Brief Case: <span class="named-content genus-species" id="named-content-1">Mycoplasma hominis</span> Extragenital Abscess
    The Brief Case
    The Brief Case: Mycoplasma hominis Extragenital Abscess
    Sarah Stabler, Emmanuel Faure, Claire Duployez, Frédéric Wallet, Rodrigue Dessein, Rémi Le Guern
  • Free
    Closing the Brief Case: <span class="named-content genus-species" id="named-content-1">Mycoplasma hominis</span> Extragenital Abscess
    The Brief Case
    Closing the Brief Case: Mycoplasma hominis Extragenital Abscess
    Sarah Stabler, Emmanuel Faure, Claire Duployez, Frédéric Wallet, Rodrigue Dessein, Rémi Le Guern

Point-Counterpoint

  • <span hwp:id="article-title-1" class="article-title">Point-Counterpoint: Should Clinical Microbiology Laboratories Report Vancomycin MICs?</span><span hwp:id="article-title-1" class="sub-article-title inherited-article-title">Point-Counterpoint: Should Clinical Microbiology Laboratories Report Vancomycin MICs?</span><span hwp:id="article-title-1" class="sub-article-title inherited-article-title">Point-Counterpoint: Should Clinical Microbiology Laboratories Report Vancomycin MICs?</span><span hwp:id="article-title-1" class="sub-article-title inherited-article-title">Point-Counterpoint: Should Clinical Microbiology Laboratories Report Vancomycin MICs?</span>
    Point-Counterpoint
    Point-Counterpoint: Should Clinical Microbiology Laboratories Report Vancomycin MICs?Point-Counterpoint: Should Clinical Microbiology Laboratories Report Vancomycin MICs?Point-Counterpoint: Should Clinical Microbiology Laboratories Report Vancomycin MICs?Point-Counterpoint: Should Clinical Microbiology Laboratories Report Vancomycin MICs?

    With numerous reported challenges to reporting MICs for vancomycin, clinical laboratories are attempting to identify accurate methods for MIC testing. However, the issues of poor reproducibility, accuracy, and clinical utility remain a challenge. In this Point-Counterpoint, Dr. Sara Revolinski discusses the pros of reporting MICs for vancomycin, while Dr. Christopher Doern argues for the use of caution.

    Sara L. Revolinski, Christopher D. Doern

Commentaries

  • Free
    On the Consequences of Poorly Defined Breakpoints for Rifampin Susceptibility Testing of <span class="named-content genus-species" id="named-content-1">Mycobacterium tuberculosis</span> Complex
    Commentary
    On the Consequences of Poorly Defined Breakpoints for Rifampin Susceptibility Testing of Mycobacterium tuberculosis Complex

    In a recent report of a systematic review of critical concentrations (CCs), the World Health Organization (WHO) lowered the rifampin (RIF) CC for antimicrobial susceptibility testing (AST) of the Mycobacterium tuberculosis complex using Middlebrook 7H10 medium and the Bactec mycobacterial growth indicator tube (MGIT) 960 system from 1 to 0.5 μg/ml. The previous RIF CC...

    Claudio U. Köser, Sophia B. Georghiou, Thomas Schön, Max Salfinger
  • Free
    Lessons in Public (Mis)communication about the Laboratory from the COVID-19 Pandemic
    Commentary
    Lessons in Public (Mis)communication about the Laboratory from the COVID-19 Pandemic

    The coronavirus disease 2019 (COVID-19) pandemic has put the clinical laboratory in the spotlight. The news media is regularly seeking out interviews with microbiologists, infectious disease specialists, and pathologists.

    Benjamin L. Mazer

Minireviews

  • Ultrasensitive Diagnostics for Low-Density Asymptomatic <span class="named-content genus-species" id="named-content-1">Plasmodium falciparum</span> Infections in Low-Transmission Settings
    Minireview
    Ultrasensitive Diagnostics for Low-Density Asymptomatic Plasmodium falciparum Infections in Low-Transmission Settings

    The emergence of multidrug-resistant Plasmodium falciparum malaria in Southeast Asia (SEA) has accelerated regional malaria elimination efforts. Most malaria in this and other low-transmission settings exists in asymptomatic individuals, which conventional diagnostic tests lack the sensitivity to detect. This has led to the development of new ultrasensitive...

    Kayvan Zainabadi
  • Value of Xpert MTB/RIF Using Bronchoalveolar Lavage Fluid for the Diagnosis of Pulmonary Tuberculosis: a Systematic Review and Meta-analysis
    Minireview
    Value of Xpert MTB/RIF Using Bronchoalveolar Lavage Fluid for the Diagnosis of Pulmonary Tuberculosis: a Systematic Review and Meta-analysis

    The performance of Xpert MTB/RIF using bronchoalveolar lavage fluid (BAL) for the diagnosis of pulmonary tuberculosis (PTB) remains unclear. Therefore, a systematic review/meta-analysis was conducted.

    Hong-Chao Liu, Yu-Lu Gao, Dan-Feng Li, Xi-Yi Zhao, Yuan-Qing Pan, Chang-Tai Zhu
  • Free
    The Importance and Challenges of Identifying SARS-CoV-2 Reinfections
    Minireview
    The Importance and Challenges of Identifying SARS-CoV-2 Reinfections

    Reports of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection have raised important questions about the strength and durability of the immune response to primary infection, which are key factors in predicting the course of the pandemic. Identifying reinfection requires detecting the virus at two different time points and using viral genomic data to distinguish reinfection from persistent viral carriage.

    ...
    Ahmed Babiker, Charles E. Marvil, Jesse J. Waggoner, Matthew H. Collins, Anne Piantadosi

Bacteriology

  • A Test for the Rapid Detection of the Cefazolin Inoculum Effect in Methicillin-Susceptible <span class="named-content genus-species" id="named-content-1">Staphylococcus aureus</span>
    Bacteriology
    A Test for the Rapid Detection of the Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus

    The cefazolin inoculum effect (CzIE) has been associated with therapeutic failures and mortality in invasive methicillin-susceptible Staphylococcus aureus (MSSA) infections. A diagnostic test to detect the CzIE is not currently available.

    Sandra Rincon, Lina P. Carvajal, Sara I. Gomez-Villegas, Aura M. Echeverri, Rafael Rios, An Dinh, Claudia Pedroza, Karen M. Ordoñez, Esteban Nannini, Zhizeng Sun, Vance G. Fowler, Barbara E. Murray, William R. Miller, Timothy Palzkill, Lorena Diaz, Cesar A. Arias, Jinnethe Reyes
  • Evaluating the Rapid Emergence of Daptomycin Resistance in <em>Corynebacterium</em>: a Multicenter Study
    Bacteriology
    Evaluating the Rapid Emergence of Daptomycin Resistance in Corynebacterium: a Multicenter Study

    Members of the genus Corynebacterium are increasingly recognized as pathobionts and can be very resistant to antimicrobial agents. Previous studies have demonstrated that Corynebacterium striatum can rapidly develop high-level daptomycin resistance (HLDR) (MIC, ≥256 μg/ml).

    Kaitlin F. Mitchell, Erin McElvania, Meghan A. Wallace, Lauren E. Droske, Amy E. Robertson, Lars F. Westblade, Carey-Ann D. Burnham
  • Open Access
    Transmission and Antibiotic Resistance of <em>Achromobacter</em> in Cystic Fibrosis
    Bacteriology
    Transmission and Antibiotic Resistance of Achromobacter in Cystic Fibrosis

    Achromobacter species are increasingly being detected in patients with cystic fibrosis (CF), and this emerging pathogen is associated with antibiotic resistance and more-severe disease outcomes. Nonetheless, little is known about the extent of transmission and antibiotic resistance development in Achromobacter infections.

    Migle Gabrielaite, Jennifer A. Bartell, Niels Nørskov-Lauritsen, Tacjana Pressler, Finn C. Nielsen, Helle K. Johansen, Rasmus L. Marvig

Mycobacteriology and Aerobic Actinomycetes

  • Free
    Low-Level Rifampin Resistance and <em>rpoB</em> Mutations in <span class="named-content genus-species" id="named-content-1">Mycobacterium tuberculosis</span>: an Analysis of Whole-Genome Sequencing and Drug Susceptibility Test Data in New York
    Mycobacteriology and Aerobic Actinomycetes
    Low-Level Rifampin Resistance and rpoB Mutations in Mycobacterium tuberculosis: an Analysis of Whole-Genome Sequencing and Drug Susceptibility Test Data in New York

    Rapid and reliable detection of rifampin (RIF) resistance is critical for the diagnosis and treatment of drug-resistant and multidrug-resistant (MDR) tuberculosis. Discordant RIF phenotype/genotype susceptibility results remain a challenge due to the presence of rpoB mutations that do not confer high levels of RIF resistance, as have been exhibited in strains with mutations such as Ser450Leu.

    Joseph Shea, Tanya A. Halse, Donna Kohlerschmidt, Pascal Lapierre, Herns A. Modestil, Cheryl H. Kearns, Felicia F. Dworkin, Jennifer L. Rakeman, Vincent Escuyer, Kimberlee A. Musser
  • Open Access
    Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania
    Mycobacteriology and Aerobic Actinomycetes
    Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania

    Rifampin or multidrug-resistant tuberculosis (RR/MDR-TB) treatment has largely transitioned to regimens free of the injectable aminoglycoside component, despite the drug class’ purported bactericidal activity early in treatment. We tested whether Mycobacterium tuberculosis

    Peter M. Mbelele, Emmanuel A. Mpolya, Elingarami Sauli, Bariki Mtafya, Nyanda E. Ntinginya, Kennedy K. Addo, Katharina Kreppel, Sayoki Mfinanga, Patrick P. J. Phillips, Stephen H. Gillespie, Scott K. Heysell, Wilber Sabiiti, Stellah G. Mpagama

Mycology

  • Categorizing Susceptibility of Clinical Isolates of <em>Candida auris</em> to Amphotericin B, Caspofungin, and Fluconazole by Use of the CLSI M44-A2 Disk Diffusion Method
    Mycology
    Categorizing Susceptibility of Clinical Isolates of Candida auris to Amphotericin B, Caspofungin, and Fluconazole by Use of the CLSI M44-A2 Disk Diffusion Method

    We evaluated the CLSI M44ed3E disk diffusion method compared with the CLSI M27ed4 broth microdilution method for caspofungin and fluconazole and the Etest method for amphotericin B to categorize susceptibility of 347 clinical isolates of Candida auris. Utilizing the zone diameter cutoffs established here, we observed overall categorical agreement between the two...

    Natalie S. Nunnally, Tajah Damm, Shawn R. Lockhart, Elizabeth L. Berkow
  • Performance of Two Novel Chromogenic Media for the Identification of Multidrug-Resistant <span class="named-content genus-species" id="named-content-1">Candida auris</span> Compared with Other Commercially Available Formulations
    Mycology
    Performance of Two Novel Chromogenic Media for the Identification of Multidrug-Resistant Candida auris Compared with Other Commercially Available Formulations

    Non-albicans Candida species are emerging in the nosocomial environment, with the multidrug-resistant (MDR) species Candida auris being the most notorious example. Consequently, rapid and accurate species identification has become essential.

    Auke W. de Jong, Chendo Dieleman, Mauricio Carbia, Ratna Mohd Tap, Ferry Hagen

Virology

  • Free
    Assessment of Sample Pooling for Clinical SARS-CoV-2 Testing
    Virology
    Assessment of Sample Pooling for Clinical SARS-CoV-2 Testing

    Accommodating large increases in sample workloads has presented a major challenge to clinical laboratories during the coronavirus disease 2019 (COVID-19) pandemic. Despite the implementation of automated detection systems and previous efficiencies, including barcoding, electronic data transfer, and extensive robotics, capacities have struggled to meet the demand.

    Sara B. Griesemer, Greta Van Slyke, Kirsten St. George
  • Free
    Pooling of Nasopharyngeal Swab Samples To Overcome a Global Shortage of Real-Time Reverse Transcription-PCR COVID-19 Test Kits
    Virology
    Pooling of Nasopharyngeal Swab Samples To Overcome a Global Shortage of Real-Time Reverse Transcription-PCR COVID-19 Test Kits

    The global outbreak and rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created an urgent need for large-scale testing of populations. There is a demand for high-throughput testing protocols that can be used for efficient and rapid testing of clinical specimens. We evaluated a pooled PCR protocol for testing nasopharyngeal (NP) swabs using known positive/negative and untested clinical samples that were...

    Sunil More, Sai Narayanan, Girish Patil, Parna Ghosh, Samuel Pushparaj, Emily Cooper, Jerry Ritchey, Vinay K. Cheruvu, Anil Kaul, Akhilesh Ramachandran
  • Free
    Comparison of Antibody Class-Specific SARS-CoV-2 Serologies for the Diagnosis of Acute COVID-19
    Virology
    Comparison of Antibody Class-Specific SARS-CoV-2 Serologies for the Diagnosis of Acute COVID-19

    Accurate diagnosis of acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is critical for appropriate management of patients with this disease. We examined the possible complementary role of laboratory-developed class-specific clinical serology in assessing SARS-CoV-2 infection in hospitalized patients.

    Hans Verkerke, Michael Horwath, Bejan Saeedi, Darra Boyer, Jerry W. Allen, Joshua Owens, Connie M. Arthur, Hirotomo Nakahara, Jennifer Rha, Kashyap Patel, Shang-Chuen Wu, Anu Paul, Nini Yasin, Jianmei Wang, Sooncheon Shin, DeAndre Brown, Katherine Normile, Lisa Cole, Mark Meyers, Heather Lin, Emily Woods, Jennifer Isaac, Kari Broder, Jenna Wade, Robert C. Kauffman, Ravi Patel, Cassandra D. Josephson, Stacian Reynolds, Melanie Sherman, Jens Wrammert, David Alter, Jeannette Guarner, John D. Roback, Andrew Neish, Sean R. Stowell
  • Open Access
    A Scalable, Easy-to-Deploy Protocol for Cas13-Based Detection of SARS-CoV-2 Genetic Material
    Virology
    A Scalable, Easy-to-Deploy Protocol for Cas13-Based Detection of SARS-CoV-2 Genetic Material

    The COVID-19 pandemic has created massive demand for widespread, distributed tools for detecting SARS-CoV-2 genetic material. The hurdles to scalable testing include reagent and instrument accessibility, availability of highly trained personnel, and large upfront investment.

    Jennifer N. Rauch, Eric Valois, Sabrina C. Solley, Friederike Braig, Ryan S. Lach, Morgane Audouard, Jose Carlos Ponce-Rojas, Michael S. Costello, Naomi J. Baxter, Kenneth S. Kosik, Carolina Arias, Diego Acosta-Alvear, Maxwell Z. Wilson
  • Open Access
    A Fast and Accessible Method for the Isolation of RNA, DNA, and Protein To Facilitate the Detection of SARS-CoV-2
    Virology
    A Fast and Accessible Method for the Isolation of RNA, DNA, and Protein To Facilitate the Detection of SARS-CoV-2

    Management of the coronavirus disease 2019 (COVID-19) pandemic requires widespread testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A main limitation for widespread SARS-CoV-2 testing is the global shortage of essential supplies, among them RNA extraction kits.

    Jose Carlos Ponce-Rojas, Michael S. Costello, Duncan A. Proctor, Kenneth S. Kosik, Maxwell Z. Wilson, Carolina Arias, Diego Acosta-Alvear
  • Free
    Self-Collected Saline Gargle Samples as an Alternative to Health Care Worker-Collected Nasopharyngeal Swabs for COVID-19 Diagnosis in Outpatients
    Virology
    Self-Collected Saline Gargle Samples as an Alternative to Health Care Worker-Collected Nasopharyngeal Swabs for COVID-19 Diagnosis in Outpatients

    We assessed the performance, stability, and user acceptability of swab-independent self-collected saliva and saline mouth rinse/gargle sample types for the molecular detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in adults and school-aged children. Outpatients who had recently been diagnosed with COVID-19 or were presenting with suspected COVID-19 were asked to have a nasopharyngeal (NP) swab collected and...

    David M. Goldfarb, Peter Tilley, Ghada N. Al-Rawahi, Jocelyn A. Srigley, Geoffrey Ford, Heather Pedersen, Abhilasha Pabbi, Stephanie Hannam-Clark, Marthe Charles, Michelle Dittrick, Vijay J. Gadkar, Jeffrey M. Pernica, Linda M. N. Hoang
  • Open Access
    A New SARS-CoV-2 Dual-Purpose Serology Test: Highly Accurate Infection Tracing and Neutralizing Antibody Response Detection
    Virology
    A New SARS-CoV-2 Dual-Purpose Serology Test: Highly Accurate Infection Tracing and Neutralizing Antibody Response Detection

    Many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serology tests have proven to be less accurate than expected and do not assess antibody function as neutralizing, correlating with protection from reinfection. A new assay technology measuring the interaction of the purified SARS-CoV-2 spike protein receptor binding domain (RBD) with the extracellular domain of the human angiotensin-converting enzyme 2 (hACE2) receptor...

    Sean C. Taylor, Beth Hurst, Carmen L. Charlton, Ashley Bailey, Jamil N. Kanji, Mary K. McCarthy, Thomas E. Morrison, Leah Huey, Kyle Annen, Melkon G. DomBourian, Vijaya Knight
  • Free
    Evaluation of the Xpert Xpress SARS-CoV-2/Flu/RSV Assay for Simultaneous Detection of SARS-CoV-2, Influenza A and B Viruses, and Respiratory Syncytial Virus in Nasopharyngeal Specimens
    Virology
    Evaluation of the Xpert Xpress SARS-CoV-2/Flu/RSV Assay for Simultaneous Detection of SARS-CoV-2, Influenza A and B Viruses, and Respiratory Syncytial Virus in Nasopharyngeal Specimens

    Patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A (flu A), influenza B (flu B), and respiratory syncytial virus (RSV) have overlapping clinical presentations, but the approaches to treatment and management of infections caused by these viruses are different. Therefore, rapid diagnosis in conjunction with infection prevention measures is important to prevent transmission of the diseases....

    Eddie Chi-man Leung, Viola Chi-ying Chow, May Kin-ping Lee, Kevin Pui-san Tang, Daniel Kwok-cheung Li, Raymond Wai-man Lai
  • Free
    Performance of Saliva Specimens for the Molecular Detection of SARS-CoV-2 in the Community Setting: Does Sample Collection Method Matter?
    Virology
    Performance of Saliva Specimens for the Molecular Detection of SARS-CoV-2 in the Community Setting: Does Sample Collection Method Matter?

    Data on the performance of saliva specimens for diagnosing coronavirus disease 2019 (COVID-19) in ambulatory patients are scarce and inconsistent. We assessed saliva-based specimens for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by reverse transcriptase PCR (RT-PCR) in the community setting and compared three different collection methods.

    Marta Fernández-González, Vanesa Agulló, Alba de la Rica, Ana Infante, Mar Carvajal, José Alberto García, Nieves Gonzalo-Jiménez, Claudio Cuartero, Montserrat Ruiz-García, Carlos de Gregorio, Manuel Sánchez, Mar Masiá, Félix Gutiérrez
  • Free
    Correlation of SARS-CoV-2 Nucleocapsid Antigen and RNA Concentrations in Nasopharyngeal Samples from Children and Adults Using an Ultrasensitive and Quantitative Antigen Assay
    Virology
    Correlation of SARS-CoV-2 Nucleocapsid Antigen and RNA Concentrations in Nasopharyngeal Samples from Children and Adults Using an Ultrasensitive and Quantitative Antigen Assay

    Diagnosis of COVID-19 by PCR offers high sensitivity, but the utility of detecting samples with high cycle threshold (CT) values remains controversial. Currently available rapid diagnostic tests (RDTs) for SARS-CoV-2 nucleocapsid antigens (Ag) have sensitivity well below PCR.

    Nira R. Pollock, Timothy J. Savage, Hanna Wardell, Rose A. Lee, Anu Mathew, Martin Stengelin, George B. Sigal
  • Free
    Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting
    Virology
    Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting

    We compared the performance of the Abbott BinaxNOW COVID-19 antigen card to that of a standard reverse transcription-PCR (RT-PCR) assay (Thermo Fisher TaqPath COVID-19 Combo kit) for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2,645 asymptomatic students presenting for screening at the University of Utah. SARS-CoV-2 RNA was detected in 1.7% of the study participants by RT-PCR.

    Nkemakonam C. Okoye, Adam P. Barker, Kenneth Curtis, Richard R. Orlandi, Emily A. Snavely, Cameron Wright, Kimberly E. Hanson, Lauren N. Pearson

Immunoassays

  • Open Access
    Performance Characteristics of the Vidas SARS-CoV-2 IgM and IgG Serological Assays
    Immunoassays
    Performance Characteristics of the Vidas SARS-CoV-2 IgM and IgG Serological Assays

    The COVID-19 pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread worldwide. Serological testing for SARS-CoV-2-specific antibodies plays an important role in understanding and controlling the pandemic, notably through epidemiological surveillance.

    Nathalie Renard, Soizic Daniel, Nadège Cayet, Matthieu Pecquet, Frédérique Raymond, Sylvie Pons, Julien Lupo, Carole Tourneur, Catherine Pretis, Guillaume Gerez, Patrick Blasco, Maxime Combe, Imen Canova, Mylène Lesénéchal, Franck Berthier
  • Novel Genetic Constructs for Production of Recombinant HTLV-1/2 Antigens and Evaluation of Their Reactivity to Plasma Samples from HTLV-1-Infected Patients
    Immunoassays
    Novel Genetic Constructs for Production of Recombinant HTLV-1/2 Antigens and Evaluation of Their Reactivity to Plasma Samples from HTLV-1-Infected Patients

    Human T-cell leukemia virus type 1 (HTLV-1) can cause life-threatening diseases for which there are no effective treatments. Prevention of HTLV-1 infection requires massive testing of pregnant women, blood for transfusion, and organs for transplantation, as well as safe sex.

    Ueriton Dias de Oliveira, Fred Luciano Neves Santos, Bernardo Galvão-Castro, Marco Aurelio Krieger, Nilson Ivo Tonin Zanchin
  • Free
    Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation
    Immunoassays
    Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). While molecular-based testing is used to diagnose COVID-19, serologic testing of antibodies specific to SARS-CoV-2 is used to detect past infection.

    Victoria Higgins, Anselmo Fabros, Vathany Kulasingam

Epidemiology

  • Genetic Evaluation of Nosocomial <span class="named-content genus-species" id="named-content-1">Candida auris</span> Transmission
    Epidemiology
    Genetic Evaluation of Nosocomial Candida auris Transmission

    Whole-genome sequences of Candida auris isolates from nosocomial and nonnosocomial infections were compared. The average numbers of single nucleotide variations were different between the two groups. The small amount of genetic variability between intra- or interhost isolates suggests recovery of all colonizing or infecting genomes for comparison is required for...

    Scott C. Roberts, Teresa R. Zembower, Egon A. Ozer, Chao Qi

Letters to the Editor

  • <em>Bordetella hinzii</em>: an Unusual Pathogen in Human Urinary Tract Infection
    Letter to the Editor
    Bordetella hinzii: an Unusual Pathogen in Human Urinary Tract Infection
    Nived Collercandy, Camille Petillon, Maryam Abid, Charlotte Descours, Claudia Carvalho-Schneider, Laurent Mereghetti, Marie-Frederique Lartigue
  • Neglecting Genetic Diversity Hinders Timely Diagnosis of <em>Cryptococcus</em> Infections
    Letter to the Editor
    Neglecting Genetic Diversity Hinders Timely Diagnosis of Cryptococcus Infections
    Dongmei Shi, Pieter-Jan Haas, Teun Boekhout, Rosane C. Hahn, Ferry Hagen
  • New Locus for <span class="named-content genus-species" id="named-content-1">Candida glabrata</span> Sequence-Based Strain Typing Provides Evidence for Nosocomial Transmission
    Letter to the Editor
    New Locus for Candida glabrata Sequence-Based Strain Typing Provides Evidence for Nosocomial Transmission
    Santosh Katiyar, Tom Edlind
  • Comparing BioFire FilmArray BCID2 and BCID Panels for Direct Detection of Bacterial Pathogens and Antimicrobial Resistance Genes from Positive Blood Cultures
    Letter to the Editor
    Comparing BioFire FilmArray BCID2 and BCID Panels for Direct Detection of Bacterial Pathogens and Antimicrobial Resistance Genes from Positive Blood Cultures
    Venere Cortazzo, Tiziana D’Inzeo, Liliana Giordano, Giulia Menchinelli, Flora Marzia Liotti, Barbara Fiori, Flavio De Maio, Francesco Luzzaro, Maurizio Sanguinetti, Brunella Posteraro, Teresa Spanu
  • Free
    A Novel Point Mutation in the N Gene of SARS-CoV-2 May Affect the Detection of the Virus by Reverse Transcription-Quantitative PCR
    Letter to the Editor
    A Novel Point Mutation in the N Gene of SARS-CoV-2 May Affect the Detection of the Virus by Reverse Transcription-Quantitative PCR
    Mohammad Rubayet Hasan, Sathyavathi Sundararaju, Chidambaram Manickam, Faheem Mirza, Hamad Al-Hail, Stephan Lorenz, Patrick Tang

Erratum

  • Free
    Erratum for Borman and Johnson, “Name Changes for Fungi of Medical Importance, 2018 to 2019”
    Erratum
    Erratum for Borman and Johnson, “Name Changes for Fungi of Medical Importance, 2018 to 2019”
    Andrew M. Borman, Elizabeth M. Johnson

Masthead

  • Free
    Editorial Board
    Masthead
    Editorial Board
Previous
Back to top

Journal of Clinical Microbiology: 59 (4)

In This Issue

volume 59, issue 4
  • Table of Contents (PDF)
  • Journal Cover & Description
Sign up for alerts

Jump to

  • Photo Quiz
  • Editorial
  • The Brief Case
  • Point-Counterpoint
  • Commentaries
  • Minireviews
  • Bacteriology
  • Mycobacteriology and Aerobic Actinomycetes
  • Mycology
  • Virology
  • Immunoassays
  • Epidemiology
  • Letters to the Editor
  • Erratum
  • Masthead
  • Most Read
  • Most Cited
Loading
  • Laboratory Diagnosis of COVID-19: Current Issues and Challenges
  • When To Retest: an Examination of Repeat COVID-19 PCR Patterns in an Ambulatory Population
  • Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution
  • Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation
More...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X